FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Noven Pharmaceuticals Combipatch Recall

Combipatch (estradiol/norethindrone acetate transdermal system) 0

Noven Pharmaceuticals Inc · Miami, FL

Risk level
Class II
Reported by FDA
Aug 25, 2021
Recall ID
D-0724-2021
Check your lot numberHow we source this data

Summary

Noven Pharmaceuticals recalled Combipatch starting Jul 30, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0724-2021 on Aug 25, 2021. Reason: Failed Stability Specifications; out of specification for shear. Status: Ongoing.

Why it was recalled

Failed Stability Specifications; out of specification for shear.

Product description

Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186

Lot numbers, UPCs & expiration codes

Lots: 88542 Exp. 03/2022; 88227 Exp. 12/2021; 88696 Exp. 05/2022; 89357 Exp. 08/2022

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0724-2021
Classification
Class II
Status
Ongoing
Recall initiated
Jul 30, 2021
FDA report date
Aug 25, 2021
Quantity
223,382 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Noven Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0724-2021, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Ongoing
Country
United States
Event ID
88342
Address
11960 Sw 144th St
Code information
Lots: 88542 Exp. 03/2022; 88227 Exp. 12/2021; 88696 Exp. 05/2022; 89357 Exp. 08/2022
Postal code
33186-6109
Report date
Aug 25, 2021
Product type
Drugs
Recall number
D-0724-2021
Classification
Class II
Recalling firm
Noven Pharmaceuticals Inc
Product quantity
223,382 boxes
Reason for recall
Failed Stability Specifications; out of specification for shear.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, Rx Only a) 2 Systems NDC 68968-0514-2 b) 8 Systems NDC 68968-0514-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186
Distribution pattern
Nationwide.
Recall initiation date
Jul 30, 2021
Initial firm notification
Letter
Center classification date
Aug 13, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0724-2021, published Aug 25, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls